If you read about apr-246 - you see mention in various articles
"lead program APR-246, a first-in-class anticancer compound reactivating the tumor suppressor protein p53". OR "the only drug in clinical trial targeting p53"
Despite completion of P1 for K and good results - K does not get mentioned - what is missing?